[HTML][HTML] Efficacy of a device to narrow the coronary sinus in refractory angina

S Verheye, EM Jolicœur, MW Behan… - … England Journal of …, 2015 - Mass Medical Soc
Background Many patients with coronary artery disease who are not candidates for
revascularization have refractory angina despite standard medical therapy. The balloon-expandable, …

Treatment of refractory angina in patients not suitable for revascularization

TD Henry, D Satran, EM Jolicoeur - Nature Reviews Cardiology, 2014 - nature.com
A growing number of patients, particularly those with advanced, chronic coronary artery disease,
experience symptoms of angina that are refractory to treatment with β-blockers, calcium-…

Epidemiology, management strategies, and outcomes of patients with chronic total coronary occlusion

L Azzalini, EM Jolicoeur, M Pighi, X Millán… - The American journal of …, 2016 - Elsevier
Factors influencing the management of patients with chronic total occlusion (CTO) are poorly
described. We sought to analyze the clinical and angiographic variables influencing the …

Clinical trial principles and endpoint definitions for paravalvular leaks in surgical prosthesis

…, V Jelnin, H Jilaihawi, EM Jolicoeur… - European heart …, 2018 - academic.oup.com
The VARC (Valve Academic Research Consortium) for transcatheter aortic valve
replacement set the standard for selecting appropriate clinical endpoints reflecting safety and …

The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34+ Cell Administration in Patients With Refractory Angina

…, AM Zeiher, CJ White, DJ Stewart, EM Jolicoeur… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives : This study tested whether intramyocardial (IM) administration of mobilized, purified
autologous CD34 + cells would improve total exercise time (TET) and angina frequency …

Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines

…, SL Carroll, JC Victor, PL L'allier, EM Jolicoeur… - Canadian Journal of …, 2012 - Elsevier
Refractory angina (RFA) is a debilitating disease characterized by cardiac pain resistant to
conventional treatments for coronary artery disease including nitrates, calcium-channel and β-…

Transcatheter reduction of paravalvular leaks: a systematic review and meta-analysis

X Millán, S Skaf, L Joseph, C Ruiz, E García… - Canadian Journal of …, 2015 - Elsevier
E. Marc Jolicœur is supported by research grants from les Fonds la Recherche du Québec
en santé (FRQS), the Canadian Institutes for Health Research (CIHR), and by la Fondation de …

Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of …

…, JH Traverse, RA Schatz, EM Jolicoeur… - European heart …, 2018 - academic.oup.com
E Marc Jolicoeur , E Marc Jolicoeur … interactive voice response system daily diary in ACT-34,
and an electronic tablet based capture system in RENEW, in which patients entered daily …

Clopidogrel use and bleeding after coronary artery bypass graft surgery

…, LK Shaw, AJ Lodge, PK Smith, EM Jolicoeur… - American heart …, 2008 - Elsevier
… A variety of electronic sources of information were used to obtain the analysis data for this
… Clare, and E. Marc Jolicoeur have no financial disclosures to report. Financial disclosures …

The benefits conferred by radial access for cardiac catheterization are offset by a paradoxical increase in the rate of vascular access site complications with femoral …

L Azzalini, K Tosin, M Chabot-Blanchet, R Avram… - JACC: Cardiovascular …, 2015 - jacc.org
Objectives : The purpose of this study was to assess whether the benefits conferred by
radial access (RA) at an individual level are offset by a proportionally greater incidence of …